Company insight
Operate with the agility you need in the facility of the future
To meet pharma industry challenges requires more agile and flexible manufacturing. Rockwell Automation provides highly integrated control and information solutions for greater productivity, increased efficiency and lower risk.
onnected, flexible operations can increase efficiencies, support smaller batches and get your products to market faster. How will an operator describe the biopharmaceutical production facility they work on ten years from now? They likely won’t mention fixed equipment or long runs. Instead, they’ll describe mobile process equipment whirling from one production area to another, as one small batch ends and another begins. They’ll mention they always have a tablet on hand. And they’ll use an augmented reality (AR) headset to provide digital work instructions and confirm proper connections are made.
C
This is the facility of the future. It can make you more competitive with lower capital costs, more efficient production and faster start-ups. And it can help you better serve patients by creating more targeted medicines and getting life-saving drugs to market faster.
With advancements in cellular biology and gene therapy, bioprocessing is changing and a shift is taking place towards smaller volume and more personalised drugs developed in multiproduct facilities.
It’s agile. Modular equipment and single-use technology can create ‘plug and play’ operations that reduce changeover times and support smaller batches. Pretested and validated
“This is the facility of the future. It can make you more competitive with lower capital costs, more efficient production and faster start-ups.”
So, what exactly is the facility of the future? It’s open. Mobile equipment and materials can be wheeled in and out of production areas. As this happens, the production system can confirm that equipment is connected in the right place and that the right product is being made. It’s connected. Systems are linked and can talk to each other. And information can guide workers through production and equipment set-up steps.
46
equipment can drastically reduce start-up times. And reduced cleaning demands can shorten product changeover times moving from one personalised batch to the next, resulting in increased production and profitability.
Where today’s facilities fall short To understand why a facility of the future is business critical, you need only look at how bioprocessing is changing.
Cellular biology and gene therapy advancements have opened the door for smaller volume and more personalised drugs. As a result, biotech manufacturing is shifting from bulk production to multiproduct facilities. These facilities require complicated batching, frequent changeovers and meticulous tracking. There’s also a shift under way from large, global facilities to smaller, localised operations. This can help you bring API production to more cost-effective locations. It allows you to make personalised medicines closer to those who need them. Finally, the need to get to market faster at competitive costs, while maintaining compliance and data integrity, is more critical now than it ever has been. You need greater process management, smarter operations and more efficient R&D operations to accelerate regulatory approval and production. Facilities of the future bring much lower capital costs.
World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
Motortion Films/
Shutterstock.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65
